Salerno Pharmaceuticals
Newport Beach, US · Founded 2016 · Delaware limited partnership
Founders & leadership
EM
Edward McKennaManager of Issuer's General Partner
TW
Thomas W. Courtney, Jr.Manager of Issuer's General Partner
Reported raises · per SEC filings
Form D private placements$6.1M disclosed across 2 rounds · 2017–2019
▶$625.4KraisedJul 2019 · 11 investors · PharmaceuticalsRule 506(b)
▶$625.4KraisedJul 2019 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Edward McKennaExecutive Officer
- Thomas W. Courtney, Jr.Executive Officer
- Offering amount
- $1.8M
- Amount sold
- $625.4K
- First sale
- Jul 2019
- Incorporated
- Limited Partnership, Delaware, 2016
- Federal exemptions
- 06b
▶$5.5MraisedFeb 2017 · 41 investors · PharmaceuticalsRule 506(b)
▶$5.5MraisedFeb 2017 · 41 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas W. Courtney, Jr.Executive Officer
- Edward McKennaExecutive Officer
- Offering amount
- $5.5M
- Amount sold
- $5.5M
- Proceeds to insiders
- $185.8K
- First sale
- Feb 2017
- Incorporated
- Limited Partnership, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Salerno Pharmaceuticals raised?
- Salerno Pharmaceuticals has disclosed $6.1M raised across 2 rounds.
- Where is Salerno Pharmaceuticals headquartered?
- Salerno Pharmaceuticals is headquartered in Newport Beach, US.